Cybin (HELP) Share-based Compensation (2020 - 2026)

Cybin (HELP) posted quarterly Share-based Compensation of $5.3 million for Q1 2026, up 260.33% year-on-year from $1.5 million in Q1 2025, and up 17.4% on a QoQ basis from $4.5 million in Q4 2025.

Cybin (HELP) Share-based Compensation (2020 - 2026) Analysis & Trends

Cybin (HELP) has reported Share-based Compensation for 7 consecutive years, with $5.3 million the latest figure, recorded in Q1 2026.

  • Quarterly Share-based Compensation rose 260.33% year-over-year to $5.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.9 million (down 65.28% YoY) and the FY2026 annual result came in at $10.9 million, down 65.27% from the prior year.
  • Share-based Compensation grew to $5.3 million in Q1 2026 per HELP's latest filing, from $4.5 million in the prior quarter.
  • Over the last five years, Share-based Compensation for HELP reached as high as $24.5 million in Q3 2024 and fell as low as -$10.0 million in Q1 2023.
  • A 5-year average of $2.3 million and a median of $949176.9 in 2023 frame the typical range for Share-based Compensation.
  • Annual changes were most pronounced in 2024 — Share-based Compensation surged 2225.56% — and 2025, when it slumped 98.46%.
  • Year by year, Share-based Compensation stood at $720495.5 in 2022, then jumped by 912.15% to $7.3 million in 2023, then plunged by 67.19% to $2.4 million in 2024, then jumped by 87.14% to $4.5 million in 2025, then increased by 17.4% to $5.3 million in 2026.
  • According to Business Quant data, Share-based Compensation over the past three periods registered $5.3 million, $4.5 million, and $377000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 6.39 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 9.26 Mn
4 NuCana 279.75 Bn 279.75 Bn - 1.18 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 166.40 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 257.40 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 87.30 Mn
10 Cybin 28.04 Mn 28.04 Mn - 5.26 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 5.26 Mn
Mar 31, 2026 5.26 Mn
Dec 31, 2025 4.48 Mn
Dec 31, 2025 4.48 Mn
Sep 30, 2025 377,000.00
Sep 30, 2025 377,000.00
Jun 30, 2025 753,000.00
Jun 30, 2025 753,000.00
Mar 31, 2025 1.46 Mn
Mar 31, 2025 1.46 Mn
Dec 31, 2024 2.39 Mn
Dec 31, 2024 2.39 Mn
Sep 30, 2024 24.53 Mn
Sep 30, 2024 24.53 Mn
Jun 30, 2024 2.90 Mn
Jun 30, 2024 2.90 Mn
Mar 31, 2024 941,741.66
Mar 31, 2024 941,741.66
Dec 31, 2023 7.29 Mn
Dec 31, 2023 7.29 Mn